Litcius/Paper detail

Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias

Vamsi Kota, Tim H. Brümmendorf, Carlo Gambacorti‐Passerini, Jeff H. Lipton, Dong‐Wook Kim, Fiona An, Eric Leip, Rocco J. Crescenzo, Roxanne Ferdinand, Jörge E. Cortes

2021Leukemia Research25 citationsDOI

Topics & Concepts

BosutinibMedicineOncologyReduction (mathematics)Internal medicineImatinibDasatinibGeometryMyeloid leukemiaMathematicsChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia research
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias | Litcius